BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Response to oxidative stress
,
Diabetes mellitus
,
Liver
,
Avian flu virus
,
rs4950928
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
daf 1
Summary
General Info
Curated Studies
Most Correlated Studies
Expression analysis of ER stress response in C. elegans
C. elegans responses to DNA damage and starvation in xpa-1, daf-2 and daf-16 mutant L1 larvae
Expression analysis of C. elegans with mutant daf-9 or daf-12
C. elegans mutants with longevity phenotype (rsks-1, daf-2, daf-16)
Late L4 stage C. elegans with daf-2 loss-of-function mutation and daf-16 or pmk-1 deletions
Explore Curated Studies Results
Literature
Most Relevant Literature
The orphan ligand, activin C, signals through activin receptor-like kinase 7.
Sustained anti-obesity effects of life-style change and anti-inflammatory interventions after condit…
ALK7 Promotes Vascular Smooth Muscle Cells Phenotypic Modulation by Negative Regulating PPARĪ³ Expres…
Alk7 Depleted Mice Exhibit Prolonged Cardiac Repolarization and Are Predisposed to Ventricular Arrhy…
ALK7 protects against pathological cardiac hypertrophy in mice.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Effect of Hypoxic and Normoxic Cerebral Oximetry Levels on Cognitive Functions After Carotid End…
Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04)
The Effect of the Non-invasive Brain Stimulation on the Speech Fluency Enhancement
A Study of the Intratumoural Administration of CAVATAK to Head and Neck Cancer Patients (VLA-X06)
CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ